Literature DB >> 1132082

Angiotensin III: (DES-Aspartic Acid-1)-Angiotensin II. Evidence and speculation for its role as an important agonist in the renin - angiotensin system.

T L Goodfriend, M J Peach.   

Abstract

Evidence is reviewed that three and possibly four peptides formed from renin substrate have biological activity that merits their recognition as agonists. The decepeptide angiotensin I affects sites in the central nervous system and adrenal medulla. The octapeptide angiotensin II affects vascular and cardiac sites that mediate acute pressor responses, and also causes direct feedback inhibition of renin release. The heptapeptide (des-asp-1)-angiotensin II ("angiotensin III") stimulates aldosterone release.. It may exert its effects intracellularly at the adrenal glomerulosa and other sites. The fourth candidate is the (des-asp-1)-angiotensin I nonapeptide, but nothing is known of its activity or circulating levels. This formulation of the angiotensin reaction sequence and the effects of its individual congeners suggests several experiments. It also permits simple explanations for previously confusing data, such as the inability of immunization and anti-angiotensin II to prevent aldosterone responses, and the paradoxical preservation of adrenal responsiveness in Bartter's syndrome.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1132082     DOI: 10.1161/01.res.36.6.38

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  9 in total

1.  Obligatory Metabolism of Angiotensin II to Angiotensin III for Zona Glomerulosa Cell-Mediated Relaxations of Bovine Adrenal Cortical Arteries.

Authors:  Phillip G Kopf; Sang-Kyu Park; Anja Herrnreiter; Christian Krause; Bernard P Roques; William B Campbell
Journal:  Endocrinology       Date:  2018-01-01       Impact factor: 4.736

2.  Detection of metals and metalloproteins in the plasma of stroke patients by mass spectrometry methods.

Authors:  Phanichand Kodali; Karnakar R Chitta; Julio A Landero Figueroa; Joseph A Caruso; Opeolu Adeoye
Journal:  Metallomics       Date:  2012-09-14       Impact factor: 4.526

3.  Inhibition of the vagal component of the baroreceptor-cardioinhibitory reflex by angiotensin III in dogs and sheep.

Authors:  E R Lumbers; E K Potter
Journal:  J Physiol       Date:  1983-03       Impact factor: 5.182

4.  Capillaries of the adrenal cortex possess aminopeptidase A and angiotensin-converting-enzyme activities.

Authors:  P J Del Vecchio; J W Ryan; A Chung; U S Ryan
Journal:  Biochem J       Date:  1980-02-15       Impact factor: 3.857

5.  Angiotensin II and III metabolism and effects on steroid production in the HAC15 human adrenocortical cell line.

Authors:  Kenji Oki; Phillip G Kopf; William B Campbell; Milay Luis Lam; Takeshi Yamazaki; Celso E Gomez-Sanchez; Elise P Gomez-Sanchez
Journal:  Endocrinology       Date:  2012-12-07       Impact factor: 4.736

6.  Metabolism of angiotensin peptides by angiotensin converting enzyme 2 (ACE2) and analysis of the effect of excess zinc on ACE2 enzymatic activity.

Authors:  Yasmin Polak; Robert C Speth
Journal:  Peptides       Date:  2021-01-02       Impact factor: 3.750

7.  A system biology approach to understanding the molecular mechanisms of Gubentongluo decoction acting on IgA Nephropathy.

Authors:  Peicheng Shen; Jiaojiao Shen; Chuan Sun; Xuejun Yang; Liqun He
Journal:  BMC Complement Altern Med       Date:  2016-08-24       Impact factor: 3.659

8.  Deciphering the link between Diabetes mellitus and SARS-CoV-2 infection through differential targeting of microRNAs in the human pancreas.

Authors:  E Pathak; R Mishra
Journal:  J Endocrinol Invest       Date:  2021-10-20       Impact factor: 5.467

9.  Immunohistochemical Localization of AT1a, AT1b, and AT2 Angiotensin II Receptor Subtypes in the Rat Adrenal, Pituitary, and Brain with a Perspective Commentary.

Authors:  Courtney Premer; Courtney Lamondin; Ann Mitzey; Robert C Speth; Mark S Brownfield
Journal:  Int J Hypertens       Date:  2013-03-19       Impact factor: 2.420

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.